Cargando…
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
Autores principales: | Sanborn, Rachel, Boulmay, Brian, Li, Rui, Spieler, Bradley, Happel, Kyle, Paustian, Christopher, Mougdil, Tarsem, Feng, Zipei, Dubay, Christopher, Fisher, Brenda, Koguchi, Yoshinobu, Aung, Sandra, Mederos, Eileen, Bifulco, Carlo, McNamara, Michael, Bahjat, Keith S, Redmond, William, Ochoa, Augusto C, Hu, Hong Ming, Fox, Bernard, Urba, Walter, Hilton, Traci |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652497/ http://dx.doi.org/10.1186/2051-1426-3-S2-P435 |
Ejemplares similares
-
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
por: Hilton, Traci, et al.
Publicado: (2014) -
An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
por: Mougdil, Tarsem, et al.
Publicado: (2015) -
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells
por: Ye, Wei, et al.
Publicado: (2014) -
Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies
por: Moudgil, Tarsem, et al.
Publicado: (2014) -
Developing an immunotherapy strategy for the effective treatment of patients with squamous cell carcinoma of the head and neck
por: Moudgil, Tarsem, et al.
Publicado: (2013)